TrianglePUBLICATIONS · 12853344
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2003 Jul
- First author
- Dimopoulos MA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Dimopoulos MA
- type
- Author
- name
- Pouli A
- type
- Author
- name
- Zervas K
- type
- Author
- name
- Grigoraki V
- type
- Author
- name
- Symeonidis A
- type
- Author
- name
- Repoussis P
- type
- Author
- name
- Mitsouli C
- type
- Author
- name
- Papanastasiou C
- type
- Author
- name
- Margaritis D
- type
- Author
- name
- Tokmaktsis A
- type
- Author
- name
- Katodritou I
- type
- Author
- name
- Kokkini G
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Dimopoulos MA
- type
- Author
- name
- Pouli A
- type
- Author
- name
- Zervas K
- type
- Author
- name
- Grigoraki V
- type
- Author
- name
- Symeonidis A
- type
- Author
- name
- Repoussis P
- type
- Author
- name
- Mitsouli C
- type
- Author
- name
- Papanastasiou C
- type
- Author
- name
- Margaritis D
- type
- Author
- name
- Tokmaktsis A
- type
- Author
- name
- Katodritou I
- type
- Author
- name
- Kokkini G
- type
- Author
- bibliography ids
- nci-bib-4573d101245c6179f04203fe
- book metadata
- content sha256
- 37a81b18ac4f2b7e09c36f82510bfc417ff776a008f3f7243bdac0913c2b5a38
- document type
- citation
- dois
- 10.1093/annonc/mdg287
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12853344
- immutable id
- pubmed:12853344@37a81b18ac4f2b7e09c36f82510bfc417ff776a008f3f7243bdac0913c2b5a38
- journal
- abbreviation
- Ann Oncol
- issn electronic
- Source null
- issn print
- 0923-7534
- issue
- 7
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 1039-44
- volume
- 14
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12853344
- provenance
- batch id
- 2d0158fe73b50bb1a4bf
- provider
- NCBI PubMed ESummary
- record sha256
- 7e96ce62bb8e1a660df4116973858899b6aa5567e4bb2e3007957f627442f4d3
- response sha256
- d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
- retrieved at
- 2026-09-09T23:45:50.935339+00:00
- publication date
- display
- 2003 Jul
- precision
- month
- year
- 2003
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.
Preserved source evidence · Not medical advice